课题基金 / 基金详情

NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE: UNIVERSAL INFLUENZA RESEARCH

NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE: UNIVERSAL INFLUENZA RESEARCH
NIAID 流感研究和应对卓越中心：通用流感研究
批准号：
10788193
负责人：
RICHARD WEBBY
金额：
$760.48万
依托单位：
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
项目状态：
未结题
起止时间：
2021-04-01 至 2025-08-31
来源：
https://reporter.nih.gov/project-details/10788193
关键词：
AnimalsBasic ScienceCohort StudiesDisease OutcomeEnvironmental Risk FactorEvolutionHumanImmuneImmune responseImmunologic FactorsInfluenzaInfluenza vaccinationMolecularNational Institute of Allergy and Infectious DiseasePathogenicityResearchSamplingVaccinationcross immunityimprovedinfluenza infectioninfluenzavirusresponsetransmission processuniversal influenza vaccine

项目摘要

项目成果

RICHARD WEBBY的其他基金

相似基金

相关文献

中文摘要
翻译
CEIRR将确定影响流感病毒进化，出现，传播和致病性的分子，生态和/或环境因素，并表征对流感感染的免疫反应，以提高对保护和交叉保护的免疫相关性的理解。CEIRR将开展一系列活动，包括队列研究和人类和动物采样，以进一步了解流感感染、传播和疫苗接种;确定在应对流感感染和疫苗接种时决定疾病结果的免疫因素;以及研究流感病毒如何演变、适应和在人类之间以及物种间传播。
英文摘要
CEIRR will determine the molecular, ecologic and/or environmental factors that influence the evolution, emergence, transmission and pathogenicity of influenza viruses, and characterize the immune response to influenza infection to improve understanding of the immune correlates of protection and cross-protection. CEIRR will carry out a host of activities, including cohort studies and human and animal sampling to further understanding of influenza infection, transmission and vaccination; identification of immunological factors that determine disease outcome in the response to influenza infection and vaccination; and studies to determine how influenza viruses evolve, adapt and transmit between humans and at interspecies interfaces.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CEIRR: SARS-CoV-2 Research Activities
CEIRR: SARS-CoV-2 Research Activities
NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE
CEIRR: SARS-CoV-2 Research Activities
海外基金